Sndinavavian ChemoTech has signed an agreement with Diversified Consultant Group LLC that will be responsible for performing a feasibility study. This study is aiming to identify how Scandinavian ChemoTech should design a "Go-to-Market" strategy when launching its animal care product vetIQure in the USA. The US market for vetIQure is of great significance as the Cancer therapy market for pets is estimated to over USD 800 million/year and growing with a double-digit rate.